Your browser doesn't support javascript.
loading
Allosteric heat shock protein 70 inhibitors block hepatitis C virus assembly.
Khachatoorian, Ronik; Riahi, Rana; Ganapathy, Ekambaram; Shao, Hao; Wheatley, Nicole M; Sundberg, Christopher; Jung, Chun-Ling; Ruchala, Piotr; Dasgupta, Asim; Arumugaswami, Vaithilingaraja; Gestwicki, Jason E; French, Samuel W.
Afiliación
  • Khachatoorian R; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA, USA.
  • Riahi R; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA, USA.
  • Ganapathy E; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA, USA.
  • Shao H; Department of Pharmaceutical Chemistry, Institute for Neurodegenerative Diseases, University of California, San Francisco (UCSF), San Francisco, CA, USA.
  • Wheatley NM; Doe Institute for Genomics and Proteomics, University of California, Los Angeles (UCLA), Los Angeles, CA, USA.
  • Sundberg C; Department of Human Genetics, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA, USA.
  • Jung CL; Department of Medicine, David Geffen School of Medicine at University of California Los Angeles (UCLA), Los Angeles, CA, USA.
  • Ruchala P; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA, USA.
  • Dasgupta A; Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA
  • Arumugaswami V; Department of Surgery, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA, USA; Department of Surgery, The Board of Governors Regenerative Medicine Institute at Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Gestwicki JE; Department of Pharmaceutical Chemistry, Institute for Neurodegenerative Diseases, University of California, San Francisco (UCSF), San Francisco, CA, USA.
  • French SW; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA, USA; UCLA AID
Int J Antimicrob Agents ; 47(4): 289-96, 2016 Apr.
Article en En | MEDLINE | ID: mdl-27013001
ABSTRACT
The human molecular chaperones heat shock protein 70 (Hsp70) and heat shock cognate protein 70 (Hsc70) bind to the hepatitis C viral nonstructural protein 5A (NS5A) and regulate its activity. Specifically, Hsp70 is involved in NS5A-augmented internal ribosomal entry site (IRES)-mediated translation of the viral genome, whilst Hsc70 appears to be primarily important for intracellular infectious virion assembly. To better understand the importance of these two chaperones in the viral life cycle, infected human cells were treated with allosteric Hsp70/Hsc70 inhibitors (AHIs). Treatment with AHIs significantly reduced the production of intracellular virus at concentrations that were non-toxic to human hepatoma Huh7.5 cells. The supernatant of treated cultures was then used to infect naïve cells, revealing that AHIs also lowered levels of secreted virus. In contrast to their effects on virion assembly, AHIs did not impact the stability of NS5A or viral protein translation in IRES assays. These results suggest that Hsc70 plays a particularly important and sensitive role in virion assembly. Indeed, it was found that combination of AHIs with a peptide-based viral translation inhibitor exhibited additive antiviral activity. Together these results suggest that the host Hsc70 is a new antiviral target and that its inhibitors utilise a new mechanism of action.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Hepacivirus / Proteínas HSP70 de Choque Térmico / Ensamble de Virus / Inhibidores Enzimáticos Límite: Humans Idioma: En Revista: Int J Antimicrob Agents Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Hepacivirus / Proteínas HSP70 de Choque Térmico / Ensamble de Virus / Inhibidores Enzimáticos Límite: Humans Idioma: En Revista: Int J Antimicrob Agents Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos